AXIN2 and cancer: Additionally, a previous study suggested that wild‐type AXIN2 inhibits the Wnt signaling pathway; however, mutated AXIN2 dominantly activates Wnt signaling in cancer cells.57 These results implied that AXIN2 might be an initiator of the canonical pathway through dysfunction of the β‐catenin destruction complex.